AstraZeneca Corona Vaccine Resumes clinical trials in the UK September 12, 23:45
Pharmaceutical giant AstraZeneca has resumed clinical trials in the UK, saying it's safe for UK regulators to reopen the vaccine for the new coronavirus, which is being developed in collaboration with Oxford University. Was revealed on the 12th.
AstraZeneca announced on the 8th of this month that it had temporarily suspended clinical trials for the vaccine to validate safety data.
The Japanese government made a basic agreement with AstraZeneca last month to supply at least 60 million people, of which 15 million will be supplied by March next year.